Efficient Installation of Heterozygous Mutations in Human Pluripotent Stem Cells Using Prime Editing
The utility of human pluripotent stem cells (hPSCs) is greatly enhanced by the ability to introduce precise, site-specific genetic modifications with minimal off-target effects. Although Cas9 endonuclease is an exceptionally efficient gene-editing tool, its propensity for generating biallelic modifications often limits its capacity for introducing heterozygous variants. Here, we use prime editing (PE) to install heterozygous edits in over 10 distinct genetic loci, achieving knock-in efficiencies of up to 40% without the need for subsequent purification or drug selection steps. Moreover, PE enables the precise introduction of heterozygous edits in paralogous genes that are otherwise extremely challenging to achieve using endonuclease-based editing approaches. We also show that PE can be successfully combined with reprogramming to derive heterozygous induced pluripotent stem cell clones directly from human fibroblasts and peripheral blood mononuclear cells. Our findings highlight the utility of PE for generating hPSCs with complex edits and represent a powerful platform for modeling disease-associated dominant mutations and gene-dosage effects in an entirely isogenic context.
Authors
- Annabelle Suter (ORCID: https://orcid.org/0009-0002-2507-7795)
- Mirana Ramialison (ORCID: https://orcid.org/0000-0001-6315-4777)
- Fernando J. Rossello (ORCID: https://orcid.org/0000-0003-3885-8777)
- Koula Sourris
- Sara E. Howden (ORCID: https://orcid.org/0000-0002-9008-9189)
- Jia Yi Kuah
- Alison Graham
- Michael See (ORCID: https://orcid.org/0000-0002-7231-3896)
- Katerina Vlahos
- Jason Crisologo
- Chathuni Gunatilake
Institutions
- Royal Children's Hospital (AU)
- The University of Melbourne (AU)
- Australian Regenerative Medicine Institute (AU)
- Murdoch Children's Research Institute (AU)
- Monash University (AU)
Publication Details
- Journal
- The CRISPR Journal
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1177/25731599251380122
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.00